Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise - Lala, P K; Scodras, J M; Graham, C H; Lysiak, J J; Parhar, R S (Cell Immunol, 1990)